Literature DB >> 22305850

Aggregating traditional cardiovascular disease risk factors to assess the cardiometabolic health of childhood cancer survivors: an analysis from the Cardiac Risk Factors in Childhood Cancer Survivors Study.

David C Landy1, Tracie L Miller, Gabriela Lopez-Mitnik, Stuart R Lipsitz, Andrea S Hinkle, Louis S Constine, Carol A French, Amy M K Rovitelli, M Jacob Adams, Steven E Lipshultz.   

Abstract

BACKGROUND: Childhood cancer survivors are at increased risk of cardiovascular disease (CVD), which may be associated with traditional CVD risk factors. We used CVD risk aggregation instruments to describe survivor cardiometabolic health and compared their results with sibling controls.
METHODS: Traditional CVD risk factors measured in 110 survivors and 31 sibling controls between 15 and 39 years old were aggregated using Pathobiological Determinants of Atherosclerosis in Youth (PDAY) scores and the Framingham Risk Calculator (FRC) and expressed as ratios. The PDAY odds ratio represents the increased odds of currently having an advanced coronary artery lesion, and the FRC risk ratio represents the increased risk of having a myocardial infarction, stroke, or coronary death in the next 30 years. Ratios are relative to an individual of similar age and sex without CVD risk factors.
RESULTS: The median PDAY odds ratio for survivors was 2.2 (interquartile range 1.3-3.3), with 17% >4. The median FRC risk ratio was 1.7 (interquartile range 1.0-2.0), with 12% >4. Survivors and siblings had similar mean PDAY odds ratios (2.33 vs 2.29, P = .86) and FRC risk ratios (1.72 vs 1.53, P = .24). Cancer type and treatments were not associated with cardiometabolic health. There was a suggested association for physical inactivity with PDAY odds ratios (r = 0.17, P = .10) and FRC risk ratios (r = 0.19, P = .12).
CONCLUSIONS: Cardiometabolic health is poor in childhood cancer survivors but not different than that of their siblings, highlighting the importance of managing traditional CVD risk factors and considering novel exposures in survivors.
Copyright © 2012 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22305850      PMCID: PMC3374397          DOI: 10.1016/j.ahj.2011.11.008

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  38 in total

1.  Heart disease and stroke statistics--2010 update: a report from the American Heart Association.

Authors:  Donald Lloyd-Jones; Robert J Adams; Todd M Brown; Mercedes Carnethon; Shifan Dai; Giovanni De Simone; T Bruce Ferguson; Earl Ford; Karen Furie; Cathleen Gillespie; Alan Go; Kurt Greenlund; Nancy Haase; Susan Hailpern; P Michael Ho; Virginia Howard; Brett Kissela; Steven Kittner; Daniel Lackland; Lynda Lisabeth; Ariane Marelli; Mary M McDermott; James Meigs; Dariush Mozaffarian; Michael Mussolino; Graham Nichol; Véronique L Roger; Wayne Rosamond; Ralph Sacco; Paul Sorlie; Véronique L Roger; Randall Stafford; Thomas Thom; Sylvia Wasserthiel-Smoller; Nathan D Wong; Judith Wylie-Rosett
Journal:  Circulation       Date:  2009-12-17       Impact factor: 29.690

2.  Diabetes mellitus in long-term survivors of childhood cancer. Increased risk associated with radiation therapy: a report for the childhood cancer survivor study.

Authors:  Lillian R Meacham; Charles A Sklar; Suwen Li; Qi Liu; Nora Gimpel; Yutaka Yasui; John A Whitton; Marilyn Stovall; Leslie L Robison; Kevin C Oeffinger
Journal:  Arch Intern Med       Date:  2009-08-10

3.  Insulin resistance and risk factors for cardiovascular disease in young adult survivors of childhood acute lymphoblastic leukemia.

Authors:  Kevin C Oeffinger; Beverley Adams-Huet; Ronald G Victor; Timothy S Church; Peter G Snell; Andrea L Dunn; Debra A Eshelman-Kent; Robert Ross; Peter M Janiszewski; Alicia J Turoff; Sandra Brooks; Gloria Lena Vega
Journal:  J Clin Oncol       Date:  2009-06-29       Impact factor: 44.544

4.  Cardiotoxicity after childhood cancer: beginning with the end in mind.

Authors:  Steven E Lipshultz; M Jacob Adams
Journal:  J Clin Oncol       Date:  2010-02-08       Impact factor: 44.544

5.  Health status of the oldest adult survivors of cancer during childhood.

Authors:  Lisa B Kenney; Cheryl Medeiros Nancarrow; Julie Najita; Lynda M Vrooman; Monica Rothwell; Christopher Recklitis; Frederick P Li; Lisa Diller
Journal:  Cancer       Date:  2010-01-15       Impact factor: 6.860

Review 6.  Vascular complications of selected cancer therapies.

Authors:  Iyad N Daher; Edward T H Yeh
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2008-10-14

7.  Cardiovascular risk factors in adult survivors of pediatric cancer--a report from the childhood cancer survivor study.

Authors:  Lillian R Meacham; Eric J Chow; Kirsten K Ness; Kala Y Kamdar; Yan Chen; Yutaka Yasui; Kevin C Oeffinger; Charles A Sklar; Leslie L Robison; Ann C Mertens
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-01       Impact factor: 4.254

8.  Predicting the 30-year risk of cardiovascular disease: the framingham heart study.

Authors:  Michael J Pencina; Ralph B D'Agostino; Martin G Larson; Joseph M Massaro; Ramachandran S Vasan
Journal:  Circulation       Date:  2009-06-08       Impact factor: 29.690

9.  Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort.

Authors:  Daniel A Mulrooney; Mark W Yeazel; Toana Kawashima; Ann C Mertens; Pauline Mitby; Marilyn Stovall; Sarah S Donaldson; Daniel M Green; Charles A Sklar; Leslie L Robison; Wendy M Leisenring
Journal:  BMJ       Date:  2009-12-08

10.  Cause-specific late mortality among 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study.

Authors:  Ann C Mertens; Qi Liu; Joseph P Neglia; Karen Wasilewski; Wendy Leisenring; Gregory T Armstrong; Leslie L Robison; Yutaka Yasui
Journal:  J Natl Cancer Inst       Date:  2008-09-23       Impact factor: 11.816

View more
  13 in total

1.  Cardiovascular risk factors among long-term survivors of breast, prostate, colorectal, and gynecologic cancers: a gap in survivorship care?

Authors:  Kathryn E Weaver; Randi E Foraker; Catherine M Alfano; Julia H Rowland; Neeraj K Arora; Keith M Bellizzi; Ann S Hamilton; Ingrid Oakley-Girvan; Gretchen Keel; Noreen M Aziz
Journal:  J Cancer Surviv       Date:  2013-02-16       Impact factor: 4.442

Review 2.  Cardiovascular disease in adult survivors of childhood cancer.

Authors:  Steven E Lipshultz; Vivian I Franco; Tracie L Miller; Steven D Colan; Stephen E Sallan
Journal:  Annu Rev Med       Date:  2015       Impact factor: 13.739

Review 3.  Out of the frying pan and into the fire: damage-associated molecular patterns and cardiovascular toxicity following cancer therapy.

Authors:  Nicole S Klee; Cameron G McCarthy; Patricia Martinez-Quinones; R Clinton Webb
Journal:  Ther Adv Cardiovasc Dis       Date:  2017-09-15

Review 4.  Late Cardiotoxicity: Issues for Childhood Cancer Survivors.

Authors:  Jyothsna Akam-Venkata; Vivian I Franco; Steven E Lipshultz
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-07

Review 5.  Prevention of cardiotoxicity among survivors of childhood cancer.

Authors:  Kelley K Hutchins; Hani Siddeek; Vivian I Franco; Steven E Lipshultz
Journal:  Br J Clin Pharmacol       Date:  2016-10-12       Impact factor: 4.335

Review 6.  Managing chemotherapy-related cardiotoxicity in survivors of childhood cancers.

Authors:  Steven E Lipshultz; Melissa B Diamond; Vivian I Franco; Sanjeev Aggarwal; Kasey Leger; Maria Verônica Santos; Stephen E Sallan; Eric J Chow
Journal:  Paediatr Drugs       Date:  2014-10       Impact factor: 3.022

Review 7.  Pharmacogenomics as a risk mitigation strategy for chemotherapeutic cardiotoxicity.

Authors:  Brian C Jensen; Howard L McLeod
Journal:  Pharmacogenomics       Date:  2013-01       Impact factor: 2.533

8.  Individual prediction of heart failure among childhood cancer survivors.

Authors:  Eric J Chow; Yan Chen; Leontien C Kremer; Norman E Breslow; Melissa M Hudson; Gregory T Armstrong; William L Border; Elizabeth A M Feijen; Daniel M Green; Lillian R Meacham; Kathleen A Meeske; Daniel A Mulrooney; Kirsten K Ness; Kevin C Oeffinger; Charles A Sklar; Marilyn Stovall; Helena J van der Pal; Rita E Weathers; Leslie L Robison; Yutaka Yasui
Journal:  J Clin Oncol       Date:  2014-10-06       Impact factor: 44.544

Review 9.  Treatment-related cardiotoxicity in survivors of childhood cancer.

Authors:  Steven E Lipshultz; Thomas R Cochran; Vivian I Franco; Tracie L Miller
Journal:  Nat Rev Clin Oncol       Date:  2013-10-29       Impact factor: 66.675

10.  Cranial irradiation as an additional risk factor for anthracycline cardiotoxicity in childhood cancer survivors: an analysis from the cardiac risk factors in childhood cancer survivors study.

Authors:  David C Landy; Tracie L Miller; Stuart R Lipsitz; Gabriela Lopez-Mitnik; Andrea S Hinkle; Louis S Constine; M Jacob Adams; Steven E Lipshultz
Journal:  Pediatr Cardiol       Date:  2012-10-19       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.